Expert clinical management of autoimmune hepatitis in the real world.
R LiberalYnto S de BoerR J AndradeG BoumaG N DalekosA FloreaniD GleesonG M HirschfieldP InvernizziM LenziA W LohseG MacedoP MilkiewiczB TerziroliB van HoekJ M VierlingM A Heneghannull nullPublished in: Alimentary pharmacology & therapeutics (2016)
There is a wide variation in the management of patients with autoimmune hepatitis even among the most expert in the field. Although good quality evidence is lacking, there is considerable experience with second-line therapies. Future prospective studies should address these issues, so that we move from an expert- to an evidence- and personalised-based care in autoimmune hepatitis.